Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Evidence of non-tandemly repeated rDNAs and their intragenomic heterogeneity in Rhizophagus irregularis.

Maeda T, Kobayashi Y, Kameoka H, Okuma N, Takeda N, Yamaguchi K, Bino T, Shigenobu S, Kawaguchi M.

Commun Biol. 2018 Jul 10;1:87. doi: 10.1038/s42003-018-0094-7. eCollection 2018.

2.

High-Quality Genome Sequence of the Root-Knot Nematode Meloidogyne arenaria Genotype A2-O.

Sato K, Kadota Y, Gan P, Bino T, Uehara T, Yamaguchi K, Ichihashi Y, Maki N, Iwahori H, Suzuki T, Shigenobu S, Shirasu K.

Genome Announc. 2018 Jun 28;6(26). pii: e00519-18. doi: 10.1128/genomeA.00519-18.

3.

Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates.

Flashner Y, Mamroud E, Tidhar A, Ber R, Aftalion M, Gur D, Lazar S, Zvi A, Bino T, Ariel N, Velan B, Shafferman A, Cohen S.

Infect Immun. 2004 Feb;72(2):908-15.

4.

Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague.

Grosfeld H, Bino T, Flashner Y, Ber R, Mamroud E, Lustig S, Velan B, Shafferman A, Cohen S.

Adv Exp Med Biol. 2003;529:423-4. No abstract available.

PMID:
12756802
5.

Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.

Grosfeld H, Cohen S, Bino T, Flashner Y, Ber R, Mamroud E, Kronman C, Shafferman A, Velan B.

Infect Immun. 2003 Jan;71(1):374-83.

6.

Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.

Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, Bino T, Leitner M, Inbar I, Rosenberg H, Gozes Y, Barak R, Fisher M, Kronman C, Velan B, Shafferman A.

Infect Immun. 2000 Aug;68(8):4549-58.

7.
8.
9.

Regulated expression and function of the c-Myc antagonist, Mad1, during a molecular switch from proliferation to differentiation.

Cultraro CM, Bino T, Segal S.

Curr Top Microbiol Immunol. 1997;224:149-58. Review. No abstract available.

PMID:
9308238
10.

Structural modifications of the omega loop in human acetylcholinesterase.

Velan B, Barak D, Ariel N, Leitner M, Bino T, Ordentlich A, Shafferman A.

FEBS Lett. 1996 Oct 14;395(1):22-8.

11.

Alphavirus hybrid virion vaccines.

Shafferman A, Lustig S, Inbar Y, Halevy M, Schneider P, Bino T, Leitner M, Grosfeld H, Velan B, Schödel F, Cohen S.

Adv Exp Med Biol. 1996;397:41-7. No abstract available.

PMID:
8718580
12.

Electrostatic attraction by surface charge does not contribute to the catalytic efficiency of acetylcholinesterase.

Shafferman A, Ordentlich A, Barak D, Kronman C, Ber R, Bino T, Ariel N, Osman R, Velan B.

EMBO J. 1994 Aug 1;13(15):3448-55.

13.
14.

Mechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3- large granular lymphocytes.

Frey JL, Bino T, Kantor RR, Segal DM, Giardina SL, Roder J, Anderson S, Ortaldo JR.

J Exp Med. 1991 Dec 1;174(6):1527-36.

15.

Variable efficacy of interferon-alpha treatment on growth of human hepatoma cell lines in vitro.

Ilan Y, Eliakim M, Bino T, Rosenberg H, Shouval D.

Isr J Med Sci. 1988 Sep-Oct;24(9-10):505-11.

PMID:
2462550
16.

Immunocompetence in pregnancy: production of interleukin-2 by peripheral blood lymphocytes.

Hauser GJ, Lidor A, Zakuth V, Rosenberg H, Bino T, David MP, Spirer Z.

Cancer Detect Prev Suppl. 1987;1:39-42.

PMID:
3500780
17.

Human cell lines secreting lymphokines. II. BCGF production by a T hybridoma and B cell lines.

Gozes Y, Epstein N, Halmann M, Bino T, Rosenberg H, Kobiler D.

Dev Biol Stand. 1987;66:447-55.

PMID:
3495463
18.

EMC virus infection in baboons as a model for studies on antiviral substances.

Levin R, Yaari A, Gitelman J, Bino T, Rosenberg H, Kohn A.

Antiviral Res. 1986 Aug;6(5):277-83.

PMID:
3021054
19.

Induction and characterization of bovine leukocyte interferon.

Cohen S, Velan B, Bino T, Rosenberg H, Shafferman A.

Methods Enzymol. 1986;119:136-44. No abstract available.

PMID:
3762401
20.

The fate of [125I]-labeled human leukocyte-derived alpha interferon in the rat.

Rosenberg H, Madar Z, Gertler A, Rubinstein M, Bino T.

J Interferon Res. 1985 Winter;5(1):121-7.

PMID:
3989334
21.

Interleukin-2 production by cord blood lymphocytes stimulated with mitogen and in the mixed leukocyte culture.

Hauser GJ, Zakuth V, Rosenberg H, Bino T, Spirer Z.

J Clin Lab Immunol. 1985 Jan;16(1):37-40.

PMID:
3156997
22.

Interleukin-2 production and response to exogenous interleukin-2 in a patient with the acquired immune deficiency syndrome (AIDS).

Hauser GJ, Bino T, Rosenberg H, Zakuth V, Geller E, Spirer Z.

Clin Exp Immunol. 1984 Apr;56(1):14-7.

23.

Treatment of life-threatening viral infections with interferon alpha: pharmacokinetic studies in a clinical trial.

Levin S, Hahn T, Rosenberg H, Bino T.

Isr J Med Sci. 1982 Apr;18(4):439-46.

PMID:
6177663
24.

Involvement of the kidney in catabolism of human leukocyte interferon.

Bino T, Edery H, Gertler A, Rosenberg H.

J Gen Virol. 1982 Mar;59(Pt 1):39-45.

PMID:
6175730
25.

The kidney is the main site of interferon degradation.

Bino T, Madar Z, Gertler A, Rosenberg H.

J Interferon Res. 1982;2(2):301-8.

PMID:
7119510
26.

Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells.

Schattner A, Merlin G, Wallach D, Rosenberg H, Bino T, Hahn T, Levin S, Revel M.

J Interferon Res. 1981;1(4):587-94.

PMID:
6180091
27.

Absence of interferon activity during acute attacks of familial Mediterranean fever.

Aderka D, Pras M, Bino T, Rosenberg H, Weinberger A, Pinkhas J.

Biomedicine. 1980 Jul-Aug;33(4):95-6.

PMID:
6159009
28.

Pilot plant scale production of human lymphoblastoid interferon.

Reuveny S, Bino T, Rosenberg H, Traub A, Mizrahi A.

Dev Biol Stand. 1980;46:281-8.

PMID:
6154002
29.

A new cellulose-based microcarrier culturing system.

Reuveny S, Bino T, Rosenberg H, Mizrahi A.

Dev Biol Stand. 1980;46:137-45.

PMID:
6153999
30.

Effect of delta9-tetrahydrocannabinol on the membrane permeability of bull spermatozoa to potassium.

Gibermann E, Gothilf S, Shahar A, Bino T.

J Reprod Fertil. 1975 Feb;42(2):389-90. No abstract available.

PMID:
1117455
31.

In vitro effects of delta9 tetrahydrocannabinol (THC) on bull sperm.

Shahar A, Bino T.

Biochem Pharmacol. 1974 Apr 15;23(8):1341-2. No abstract available.

PMID:
4824778
32.

Biochemical effects and morphological changes in rat liver mitochondria exposed to 1 -tetrahydrocannabinol.

Bino T, Chari-Bitron A, Shahar A.

Biochim Biophys Acta. 1972 Oct 23;288(1):195-202. No abstract available.

PMID:
4264437
33.

Effect of 1-tetrahydrocannabinol on ATPase activity of rat liver mitochondria.

Chari-Bitron A, Bino T.

Biochem Pharmacol. 1971 Feb;20(2):473-5. No abstract available.

PMID:
4260786

Supplemental Content

Support Center